Abstract
Selective serotonin reuptake inhibitors are widely prescribed drugs without recognized cardiovascular risk. We report the case of a 54-year-old patient who developed QTc interval prolongation, followed by ventricular fibrillation episodes, 10 hours after admission to the ICU, in the setting of a citalopram overdose. Citalopram plasma values dropped from 5.88 to 0.34 mg/L at 9 days postadmission. The patient was treated by oral activated charcoal, and final outcome was favorable.
MeSH terms
-
Citalopram / administration & dosage
-
Citalopram / adverse effects*
-
Citalopram / blood*
-
Citalopram / therapeutic use
-
Drug Monitoring*
-
Drug Overdose
-
Electrocardiography
-
Female
-
Half-Life
-
Humans
-
Long QT Syndrome / blood
-
Long QT Syndrome / chemically induced
-
Long QT Syndrome / drug therapy
-
Middle Aged
-
Selective Serotonin Reuptake Inhibitors / administration & dosage
-
Selective Serotonin Reuptake Inhibitors / adverse effects*
-
Selective Serotonin Reuptake Inhibitors / blood*
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Treatment Outcome
-
Ventricular Fibrillation / blood
-
Ventricular Fibrillation / chemically induced
-
Ventricular Fibrillation / drug therapy
Substances
-
Serotonin Uptake Inhibitors
-
Citalopram